SomaLogic and Otsuka Enter Into Research Collaboration 13 May 2008 Otsuka to use SomaLogic's aptamer technology to discover and develop research tools to enhance pharmaceutical discovery and development efforts.
PolyMedix Receives Clearance to Initiate Phase I Clinical Study of Systemic Antibiotic Compound 13 May 2008 PMX-30063, the company’s first defensin mimetic systemic antibiotic drug cleared for human clinical trials.
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration 13 May 2008 Cytopia has out-licensed technology to Cancer Therapeutics for an undisclosed kinase enzyme target with potential for treating metastatic cancers.
ChemAxon Announces new CEO and Head of R&D 13 May 2008 Company increases its focus on business development and market position with new appointments.
ACT Biotech Acquires Clinical and Early Stage Oncology Portfolio Licenses from Bayer Healthcare 08 May 2008 ACT Biotech acquires an anti-angiogenic receptor tyrosine kinase inhibitor entering Phase II clinical studies for colorectal cancer.
Dalton Pharma Services Licenses Thermo Fisher Scientific Enter Drug Development Agreement 07 May 2008 Dalton will use a proprietary Thermo Fisher manufacturing process to produce nucleic-acid biopolymers for pharmaceutical use.
DiaKine Therapeutics and Kinexum Metabolics to Develop Combination Treatment to Type 1 Diabetes 07 May 2008 DiaKine’s Lisofylline and Kinexum’s INGAP peptide combo therapy is set for Phase 2 clinical trial.
GE Healthcare Signs Global Molecular Diagnostic Agreement to Advance Respiratory Drug Development 06 May 2008 Merck will be granted access to Spin Signal Technology™ to provide high speed, quantitative imaging of the lung using Magnetic Resonance Imaging.